1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is 4,29€ (+329,00%). The median is 4,29€ (+329,00%).
| Buy |
3 |
| Hold |
1 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Mar 2026 | |
|---|---|---|
| Revenue | 3.94m | 34,76% |
| Gross profit | 3.67m | 154,36% |
| Net profit | −94.46m | 2.567,06% |
| EBITDA | −91.19m | 2.610,52% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | 65.26m€ |
Number of shares | 73.45m |
52-week high/low | 7,82€ - 0,46€ |
| Dividends | No |
Beta | -0,24 |
P/E ratio | −0,28 |
PEG ratio | −0,01 |
P/B ratio | −1,31 |
P/S ratio | 2,91 |
Company profile
Upexi, Inc. produziert und vertreibt verschiedene Markenprodukte in den Bereichen Gesundheit, Wellness, Haustiere, Schönheit und andere Märkte. Das Unternehmen war früher als Grove, Inc. bekannt und änderte im August 2022 seinen Namen in Upexi, Inc. Upexi, Inc. wurde im Jahr 2018 gegründet und hat seinen Hauptsitz in Clearwater, Florida.
| Name | Upexi Inc |
| CEO | Allan Marshall |
| Website | |
| IPO | 06/24/2021 |
| Employees | 59 |
Deep Dive
Discover assets
Shareholders of Upexi Inc also invest in the following assets
